Duquesnoy R J, Trucco M
Department of Pathology, University of Pittsburgh School of Medicine, Pennsylvania.
Crit Rev Immunol. 1988;8(2):103-45.
In this review, the authors have analyzed the relationship between molecularly defined HLA gene polymorphisms and the diversity of HLA antigens detected serologically and by T-cell allorecognition. Although many relevant publications were not included, examples of the studies described here provide evidence for the strong association between polymorphisms defined at the gene and at the cell surface product levels. The concordance between RFLP and alloantigenic reactivity patterns may represent strong linkage disequilibrium between specific restriction enzyme variations in the coding and noncoding regions. It has become apparent that the allelic variations detected by molecular techniques are far greater than those defined by serological and cellular typing. This observation provides an impetus to identify reagents which define additional cell surface polymorphisms potentially important in immunoregulation, disease susceptibility, and transplant immunity.
在本综述中,作者分析了分子定义的HLA基因多态性与通过血清学检测及T细胞同种异体识别所检测到的HLA抗原多样性之间的关系。尽管未纳入许多相关出版物,但此处描述的研究实例为基因水平和细胞表面产物水平定义的多态性之间的强关联提供了证据。限制性片段长度多态性(RFLP)与同种抗原反应模式之间的一致性可能代表了编码区和非编码区特定限制性内切酶变异之间的强连锁不平衡。显而易见,通过分子技术检测到的等位基因变异远多于血清学和细胞分型所定义的变异。这一观察结果促使人们去鉴定能够定义在免疫调节、疾病易感性和移植免疫中可能具有重要意义的其他细胞表面多态性的试剂。